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1. Introduction
Gliclazide is an oral hypoglycemic agent and classified as a sulfonylurea of 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-p-
tolylsulphonylurea. It acts as both a first-generation1 and second-generation2 sulfonylurea to reduce blood sugar levels. This 
drug is prescribed 2 to 4 times daily depending upon the severity of the diabetes.Sustained release tablet can give the 
multiple therapeutic doses by a single administration. 
Methocel cellulose ethers are two types, methylcellulose (MC) and Hypromellose (HPMC).  Various grades of 
hypromellose is commonly used for the design of modified release tablets. 
The grades  are  ranging from 3 to  200,000 mPa’s.  Viscosity of  the  solution  depends  on  the  concentration  of  
Methocel that allows the desired level of performance for dissolution, floe properties. Hypromellose (HPMC) found as 
various branded like Methocel E, methocel F, Methocel J, and Methocel K. Premium grades of these Methocel products  
meet the specification for pharmaceutical modified release drugs.
Various types of HPMC are used in many researches to design and development of sustained release Gliclazide  
tablet. Researchers used compatible excipients such as mannitol, calcium hydrogen phosphate dehydrate, and change of 
ratio of the polymer to design the formulation. The type and concentration of HPMC influenced the rate and release of drug 
discussed by Williams  et  al3.  Another  study by Samani  et  al4 proved that  the drug release depended on the type  and 
proportion of polymer. HPMC K100M and HPMC K100 LV which is special lower grade viscosity was found better matrix 
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former for Gliclazide sustained release tablet in many research studies.
Gliclazide  has  low  has  low  solubility  and  high  permeability  for  the  variability  in  absorption  due  to  the 
physicochemical properties of gliclazide, which belongs to Class II of the biopharmaceutical classification system. For that  
reason the dissolution is the rate controlling step during drug absorption. The dissolution rate of gliclazide depends on the 
gastric emptying time and the dissolution rate in the small intestine, where the compound is soluble. 
This study employed for desired improvement in powder flow compared to conventional HPMC and in dissolution 
study with newly introduced DC grade HPMC.
2. Experimental
2.1 Materials: Gliclazide BP was obtained from Zhejiang Huayi Pharmaceutical Co. Ltd, China. Low viscosity, DC grade 
hypromellose (Premium Methocel K 100 LV CR, Methocel K 100 LV DC) and high viscosity Methocel K4M CR, Methocel  
K4M DC, Methocel K 100 M CR, Methocel K 100 M DC were obtained from Dow Chemical Company (Midland, MI 
USA). Methocel K 100 LV CR is conventional grade and Methocel K 100 LV DC, K4M DC, K 100 M DC is newly  
introduced for direct compression method which influences the flow property and dissolution rate than previous HPMC. All  
other chemicals used were of analytical grade (Merck, Germany).
K100LV DC is a lower viscosity of 100 mPa·s and Table shows the grade of other HPMC.
Table 1: Typical properties of CR and DC grade METHOCEL™
Properties Methocel K 100 
LV 
Premium CR
Methocel K 100 
LV
Premium DC
Methocel 
K4M
Premium CR 
Methocel 
K4M 
Premium DC
Methocel K 100 
M 
Premium CR
Methocel K 100 
M 
Premium DC
Viscosity (mPa·s) 80–120 80–120 2663–4970 2663–4970 72,750-135,800 72,750-135,800
Bulk densitya 
(g/cm3) 0.25–0.35 0.25–0.35 0.12–0.15 0.12–0.15 0.12–0.15 0.12–0.15 
Moisturea (%) 5% max 5% max 5% max 5% max 5% max 5% max 
  Low viscosity  High Viscosity  
   K100 LV CR à K100 LV DC à K4M CR à K4M DC à K100 M CR à K100 M DC
2.2 Method: The flow properties of powder were determined by examining of Carr’s Index and Hausner’s ratio. The bulk 
density of the powder was determined by weight of the powder divided by the volume it occupies, normally expressed as 
g/mL. Tap density was determined by subjecting the powder in a graduated cylinder to 500 taps by a standardized tapping  
procedure of USP –II method (using VTAP MATIC-II) by following equation:
The Hausner’s ratio was determined as the ratio of the initial bulk volume to the tapped volume. The Carr’s index 
was calculated using bulk and tapped densities data by following equation:
The formulations were blended with the proper amounts of ingredients in a Laboratory scale V-blender (Patterson-
Kelley, East Stroudsburg, PA USA) for the preparation of tablet. The hypromellose (HPMC)(amount described in table 2),  
Gliclazide (table 2), 98 mg of Avicel PH 102, 1 mg of Aerosil 200 were blended for 10 min. The magnesium stearate was  
then added and blended for  1 additional  minute.  Tablets were produced using a Manesty 16-station Betapress (Oystar 
Manesty, Merseyside, England). Flat-face, 3/32-inch tooling was used at 5000 lb compression force. The press was operated  
at 18 rpm. Target tablet weight was 205 mg.
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Table 2: Amounts of METHOCEL™ in Gliclazide Tablets
Tablet 
formulation
Methocel K4M 
Premium CR
Methocel K4M 
Premium DC
Methocel K100M 
Premium CR
Methocel K100M 
Premium DC
Methocel K 100 
LV Premium CR
Methocel K100 
LV Premium DC
F-1 70 --- --- --- --- ---
F-2 --- 70 --- --- --- ---
F-3 --- --- 70 --- --- ---
F-4 --- --- --- 70 --- ---
F-5 --- --- --- --- 70 ---
F-6 --- --- --- --- --- 70
Thickness and diameter of the tablets were measured by digital  Vernier calipers.  The crushing strength of the  
tablets  determined  at  room temperature  by  diametric  compression  using  a  hardness  tester  (Veego  Scientific  devices,  
Mumbai,  India).  The  percentage  friability  of  the  tablets  was  determined  using  the  tablet  friability  apparatus  (Veego 
Scientific devices, Mumbai, India) operated at 25 rpm for 4 minutes. Tablets were weighed accurately placed in the chamber 
and rotated for 4 minutes (100 rotations). At the end of the run, the dusts on the tablet cleaned carefully, weighed accurately  
again and the percent friability (f) computed from the weight of the tablets before and after the test according to the below  
equation:
where, Wo and W are the weights of tablets before and after the test respectively.
Hardness of the tablets was determined by Monsanto hardness tester and should be found within the range of 3-7 kg/cm2.
The swelling properties of the compacts in 900 mL of Phosphate buffer pH 7.4 were determined using a modified 
version of the method. The HPMC compacts was dissolved in the medium for certain time periods (15, 30, 60, 120 minutes)  
before they were removed into a pre-weighted plastic container. The excess dissolution medium was sapped and blotted  
from around the disc without touching it. The compact and the container were weighted and then the wet weight of the 
compact was established. The wet weight at each time point was determined in triplicate, and the averages and standard 
deviations were calculated. 
The relative swelling of the compacts, calculated as the ratio of the wet weight (Ww) to the initial weight (Wi) was  
determined, as an indication of the extent of matrix swelling using a similar index to Panomsuk et al. 5. 
Relative swelling = Ww / Wi
Dissolution tests were performed in a VEEGO-BDA-8DR-USP Standards dissolution bath using USP Apparatus II  
(paddles) in 900 mL of Phosphate buffer pH 7.4 at 100 rpm. Tablets were
subjected to the hydro-alcoholic media for duration of either 24 hours or 1 hour followed by 23-hour dissolution in water.  
Absorbance was measured using a dual-beam UV/Vis spectrophotometer (PerkinElmer) using 5 mm quartz cells at 228 nm 
for gliclazide. Cumulative percent release of the drug calculated for the comparative analysis of all formulations and In-
Vitro drug release performance using MS-Excel software.
Cumulative percent release was fitted to following power model in order to study the dissolution behavior and  
mechanism of drug release from matrix tablets. Q = KH. t
1/2
where, Q = Per cent Drug released at time, t, KH = Higuchi rate constant, t = Time
If the release of the drug does not depend on the concentration of the drug in the depot, then it follows the zero 
order model and the equation derived as M = M0 - K0. t
Here, M0 = Per cent drug remaining at time, t = 0. M = Per cent drug remaining at time, t = t. K = Zero order rate 
constant. t = Time.
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In the first order model, the release of the drug depends on the concentration of the drug in the depot which is expressed as 
lnC = lnC0 - K1. t
Here, C0 = Per cent drug remaining at time, t = 0. (100% drug remains), C = Per cent drug remaining at time, t = t, 
K1 = First order rate constant. t = Time.
3. Results
3.1 Evaluation of physical properties of matrix tablets: The weight, hardness, and thickness were in the range of 206.63 
mg to 203.25 mg, 4.121 kg/cm2 to 4.222 kg/cm2 and 3.78 mm to 3.58 mm, respectively. The percent friability was less than 
0.5%. The data obtained were showed in the following table 2: 
Table 3: Physical characteristics of Gliclazide Tablet
Formula Avg. Wt.  (mg.) Avg. hardness (kg/cm2) Avg. thickness (mm.) Friability  (%)
F-1 205.26 ± 4.3477 4.136 ± 0.3886 3.78 ± 0.0716 0.2554
F-2 203.76 ± 3.7427 4.121 ± 0.5801 3.58 ± 0.0716 0.1345
F-3 203.87 ± 5.3320 4.222 ± 0.6620 3.64 ± 1.3886 0.1541
F-4 206.63 ± 4.6378 4.132 ± 0.6531 3.72 ± 1.5801 0.1247
F-5 205.55 ± 4.3325 4.131 ± 0.6602 3.76 ± 1.6621 0.4512
Carr’s index, Hausner’s ratio of the powder was within the range indicating good flowability and results were 
showed in the table 3:
Table 4: Flow properties of powder
Tablet formulation Compressibility index 
(in per cent)
Hausner ratio
F1 10.142 1.291
F2 9.320 1.019
F3 10.255 1.220
F4 8.253 1.003
F5 10.050 1.279
F6 9.101 1.025
Compact  relative  swelling was  <4 in  Phosphate  buffer  pH 7.4  media  (table  5).  Higher  relative  swelling was 
recorded for K100 LV Premium CR and lower relative swelling for K100 LV Premium DC. No significant difference in  
compact swelling was observed for METHOCEL™. Any differences in drug release profiles can be explained from this 
solubility.
Table 5: Effect of Media on Relative Swelling (Ww/Wi) of Methocel Product
Tablet Formulation Methocel Relative Swelling (Ww/Wi) in Phosphate Buffer pH 7.4
15min 30min 60min 120min
F-1 K4M Premium CR 1.96 2.13 2.27 2.33
F-2 K4M Premium DC 2.00 2.12 2.29 2.73
F-3 K100 M Premium CR 2.15 2.38 2.51 2.63
F-4 K100 M Premium DC 1.44 1.47 1.48 1.50
F-5 K100 LV Premium CR 2.19 2.55 2.87 3.01
F-6 K100 LV Premium DC 1.49 1.52 1.53 1.56
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3.2 Dissolution pattern:  Dissolution test was performed for 24 hours. F1 – F6 tablets were constituted with only alone 
Methocel K100 LV CR, K100 LV DC, K4M CR, K4M DC, K100 M CR, K100 M DC. The drug release showed 100%  
release from all grade Methocel except K100 M DC of 73.25% for 24 hours. Total percent release of F1 was 99% for 18 h,  
and F2 99% for 22 h, F3 100% for 19 h, F4 73.25% for 24 h, F5 100% for 19 h, F6 100% for 19 h. 
The API Gliclazide was released 20 to 30% in early time point according to European Medicines Agency (EMEA). 
This simple formulation did not show the dose dumping problem from HPMC polymer mechanism.
Dissolution rate was analyzed with Zero order, First order and Higuchi release kinetic model but the best fitted  
model was Higuchi model (R value: 0.973) and partially fitted with zero order model (R value: 0.980) for all formulations  
except F5. First order model was not fitted for F2 to F6 except F1(R value: 0.988).
Table 4: Mathematical modeling of Gliclazide tablets.
Formulation Zero-order Higuchi 
F1 0.897 0.918
F2 0.980 0.852
F3 0.685 0.951
F4 0.961 0.890
F5 -0.253 0.712
F6 0.811 0.973
4. Discussion
Gliclazide tablets were prepared using Direct Compression (DC) and conventional grade (CR) HPMC in order to 
control the release of water insoluble Gliclazide for the detailed investigation on dissolution behavior, swelling and flow 
property. 
All the prepared Gliclazide matrix tablets showed an optimum weight variation range from 203.25 to 206.63 with 
standard deviation <5%. Tablet weight depends on the compression and blending technology and influences the hardness for 
proper drug release in the dissolution media. Flow properties of the granules have impact on tablet weight and drug release.  
Hardness  variation range of these tablets  was very minor and good for  optimum dissolution at  a  controlled rate.  The 
prepared tablets showed a uniformity of thickness. The values of tablet thickness were in range of 3.58 – 3.78 mm. The  
concentration of drug in the tablets was not <97% and found under labeled potency with standard deviation 2%. This 
obtained data complied with the Pharmacopoeial limits for content uniformity6.
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The In-Vitro study of Gliclazide tablets formulas F1, F2, F3, F5, F6 showed that the extent of drug release was 
74.32%,  57.15%,  86.91%,  35.12%,  99.31%,  77.39% respectively for  12  h(Figure  1,  Figure  2).  F1,  F2  released  99% 
gliclazide at 18 h and 22 h respectively. F3 released 100% gliclazide at 19 h and F4 73.25% at 24 hour only. Both F5, F6  
released 100% drug at 19 h.
It was depicted that Direct Compression (DC) grade Methocel can extend the release rate more than conventional  
release grade Methocel. It seemed that both F5, F6 released 100% gliclazide but the precise value depicted that DC grade is  
better. Also, DC grade allowed the better floe properties than CR grade for this custom release. 
Higher viscosity grade Methocel K100M Premium DC (72,750–135,800 mPa·s) capable to release gliclazide for 
more than 12 hours and it  was 73.25 for 24 h.  It  was described that  this ability of release rate  was better than same 
conventional CR grade Methocel and lower viscosity grade K100LV CR and K100LV DC. But the precisely K100LV DC 
was better than CR grade. 
This experiment showed more extended release was passable to design using higher grade DC Methocel alone. But 
it is predicted that combined grade of Methocel in the formulation can exted the rate of release more suitably.
The zero order released extended Gliclazide tablets showed slow release for 24 hour which was controlled and 
followed zero order kinetics and Higuchi kinetics. The percent of drug release was not depended on the concentration of  
drug in the depot. It is indicated a dependent release mechanism on the viscosity grade and concentration of the HPMC. The  
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drug release  was  poor  and  controlled  for  surface  erosion or  initial  disaggregation  of  matrix  tablets  prior  to  gel  layer  
formation around the tablet core. 
Dissolution behavior of the prepared matrix tablets was significantly different according to viscosity grades of the 
Methocel at 12 h. In-Vitro release of Gliclazide was extended with the viscosity grade of the polymer. The more extended  
release was found 73.25% for 24 h using Methocel K100M DC. 
Lower  viscosity  grade  (K100LV CR)  showed  100%  release  for  24  h.  The  release  of  the  drug  was  directly 
proportionate to the viscosity grade of the matrix tablets containing Methocel. In-Vitro drug release data showed dependent  
dissolution mechanism on the viscosity grade of the polymer. 
F2, F4 was better in terms of release profile. The reason may be for the surface erosion and diffusion of the matrix  
tablet to gel layer formation. The release may be extended for 24 h at a controlled manner and slower diffusion and erosion 
of the surface prior to gel layer formation7 was the cause of this slower release which could be extended at the desired  
release rate by determining the amount of polymer level with high or low basis. From this point of view F2, F4 tablets 
showed good formulation as the half-life of Gliclazide is 10-12 hours. The cause of this release pattern may be for the  
Higher viscosity reduced greater chain entanglement to form thicker gel barrier. This viscosity of the polymer is related to 
the molecular weight8 Previously published study of Rahman et al9showed inverse relationship between the viscosity grades 
of the polymer and drug release, but Gliclazide formulated polymeric tablets showed direct relationship. The reason for this 
may be drug-excipients interaction, diffusion mechanism and pH of the buffer 7.4. 
The release data were subjected to kinetic analysis using linear regression with Higuchi Kinetic Model (R value:  
0.973). The drug release from all formulas was found followed Higuchi model and zero order model but F5 did not fitted  
with zero order model. All tablet formulations showed a significant differences (p<0.05) in the release profiles for 12 h. The 
release followed non-Fickian diffusion9. It was observed that both diffusion of drug and relaxation of polymer controlled the 
release rate from the matrix system. 
5. Conclusion 
In this experiment the dose was not dumped and widely acceptable pH range. The method was simple and cost  
effective. Methocel K100M DC grade either provide the desired flow property and dissolution rate than previously available 
CR grade.  Also,  Methocel  K100LV DC grade  is  counterpart.  DC grade  can  be used  alone  as  per  this  experiment  or 
suggested in combination with other DC grades for further investigation on custom dissolution profile. Viscosity grades of  
the HPMC determined the rate of release at the desired level for 30 mg of Gliclazide modified release dosage form for  
promising technique for oral delivery of Gliclazide.
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